Assessing the surety of the most complex Supply Chains
Creating a unique medical solution and planning for its successful roll-out in clinical trials is a complex process – particularly when the scope of implementation is international.
Eramol provides specialist advice in this area, undertaking prospective risk assessments for end-to-end supply chains. We detail key aspects of a project such as its sustainability, together with contingency planning assessments in the event of supply and distribution complications.
We can illustrate local depot or direct-to-site distribution models, factoring in local regulatory and customs requirements for each proposed territory.
Getting your medicinal supplies manufactured and distributed across the world takes time, planning and a considered budget. Eramol ensures that all factors are addressed, leaving nothing to chance in local, and international, supply chains.
Placebo matching is a key aspect of pharmacological research, and we offer extensive, rapid and cost-effective services in the field of placebo manufacturing. We fully understand that if you are looking for a placebo to parallel your product, or designing a trial dose that matches an existing comparator, getting a good match can be challenging.
Eramol’s manufacturing authorisations include EU and UK importation and can act as the physical site of importation for products manufactured further afield, across the globe.
QP releases ensure that batches are released with the appropriate communications, data and regulations for their destination country.